Peter Nash is Professor in the School of Medicine at Griffith University, Queensland, and Director of the Rheumatology Research Unit (RRU). He currently Chairs the ASMPOC, has Chaired the Professional Affairs Committee, the Therapeutics Committee, and the NHMRC musculoskeletal panels, and served on the Scientific Advisory Committee of the Australian Rheumatology Association. and the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He is a founding member of GRAPPA and served on the International Steering Committee (GRAPPA) for a number of years. He is on the editorial board of Journal of Rheumatology, Annals of the Rheumatic Diseases and RMD Open.
Prof. Nash and his group at RRU have been involved in the pivotal registration clinical trials for all modern targeted biologic and osteoporosis therapies. He has published >230 peer-reviewed papers, 6 book chapters, and has been recognized 2021 and 2022 as Australian rheumatology leader for citations in the top 20 rheumatology journals over past 5 years. Special interests:metabolic bone disease and novel therapeutics.
